Device
LV pacing
LV pacing is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
unknown1
Recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed125%
unknown125%
recruiting125%
withdrawn125%
Recent Activity
1 active trials
Showing 4 of 4
completednot_applicable
Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB.
NCT04409119
recruitingnot_applicable
HIS Alternative II - UK Site
NCT05814263
withdrawnnot_applicable
Left Ventricular Pacing to Avoid Cardiac Enlargement Study
NCT01302717
unknownnot_applicable
Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study
NCT02314897
Clinical Trials (4)
Showing 4 of 4 trials
NCT04409119Not Applicable
Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB.
NCT05814263Not Applicable
HIS Alternative II - UK Site
NCT01302717Not Applicable
Left Ventricular Pacing to Avoid Cardiac Enlargement Study
NCT02314897Not Applicable
Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4